As Habener explains, 'Previous studies in animals had shown that GLP-1 slowed down acid secretion and stomach emptying and caused early satiety
In studies , people who lost 20% of their body weight during their first 36 weeks (89 months) on Zepbound were able to lose an additional 5.5% if they stayed on the medication another year
It is not approved for human or veterinary use and must not be used in clinical, diagnostic or therapeutic applications
In addition, peripheral once-daily administration of liraglutide produces a clinically-meaningful degree of body weight loss by reducing energy intake, and as such, liraglutide is also an approved monotherapy for treating obesity 37,38
Dosage Forms and Strengths Injection: Clear, colorless to slightly yellow solution in pre-filled single-dose pens, single-dose vials, multi-dose vials, or single-patient-use KwikPens, each available in the following strengths
Ro and LifeMD both operate in the competitive telehealth GLP-1 space, offering remote consultations and medication delivery